Tanshinone IIA promotes the chemosensitivity of breast cancer MCF-7 cells to Dox in a dose-dependent manner by downregulating the expression of efflux ABC transporters including P-gp, BCRP, and MRP1 (Li and Lai, 2017). This evidence concerns the gene ABCG2 and breast cancer.